首页> 外文期刊>International Journal of General Medicine >The discrediting of the monoamine hypothesis
【24h】

The discrediting of the monoamine hypothesis

机译:单胺假说的抹黑

获取原文
           

摘要

Background: The monoamine hypothesis has been recognized for over half a century as a reference point to understanding electrical dysfunction associated with disease states, and/or regulatory dysfunction related to synaptic, centrally acting monoamine concentrations (serotonin, dopamine, norepinephrine, and epinephrine).Methods: Organic cation transporters (OCT) are a primary force controlling intracellular and extracellular (including synaptic) concentrations of centrally acting monoamines and their amino acid precursors. A new type of research was analyzed in this paper (previously published by the authors) relating to determining the functional status of the nutritionally driven organic cation transporters. It was correlated with the claims of the monoamine hypothesis.Results: Results of laboratory assays from subjects not suffering from a hyperexcreting tumor show that centrally acting monoamine concentrations are indistinguishable in subjects with and without disease symptoms and/or regulatory dysfunction. Analysis of centrally acting monoamine concentrations in the endogenous state reveals a significant difference in day-to-day assays performed on the same subject with and without monoamine-related disease symptoms and/or regulatory dysfunction. The day-to-day difference renders baseline testing in the endogenous state non-reproducible in the same subject.Conclusion: It is asserted that the monoamine hypothesis, which claims that low synaptic levels of monoamines are a primary etiology of disease, is not a valid primary reference point for understanding chronic electrical dysfunction related to the centrally acting monoamines. Furthermore, the "bundle damage theory" is a more accurate primary model for understanding chronic dysfunction. The "bundle damage theory" advocates that synaptic monoamine levels are normal but not adequate in states associated with chronic electrical dysfunction and that levels need to be increased to compensate for the chronic postsynaptic electrical dysfunction due to existing damage. The monoamine hypothesis, in failing to accurately explain the etiology of chronic neuronal electrical flow dysfunction in the endogenous state, is reduced to no more than a historical footnote.
机译:背景:单胺假说已被认识超过半个世纪,作为理解与疾病状态相关的电功能障碍和/或与突触,中枢作用的单胺浓度(5-羟色胺,多巴胺,去甲肾上腺素和肾上腺素)有关的调节功能障碍的参考点。方法:有机阳离子转运蛋白(OCT)是控制中心作用单胺及其氨基酸前体的细胞内和细胞外(包括突触)浓度的主要作用力。本文分析了一种新类型的研究(先前由作者发表),涉及确定营养驱动的有机阳离子转运蛋白的功能状态。结果:单排胺假说的主张与结果相关。结果:来自未患有高排泄性肿瘤的受试者的实验室检测结果表明,在有或没有疾病症状和/或调节功能障碍的受试者中,中枢作用的单胺浓度是无法区分的。对内源性状态的中枢作用单胺浓度的分析显示,在有和没有单胺相关疾病症状和/或调节功能障碍的情况下,对同一受试者进行的日常测定存在显着差异。每天的差异使得同一受试者在内源性状态下的基线测试不可重现。结论:有人断言单胺假说声称低突触水平的单胺是疾病的主要病因,但并非一概而论。理解与中枢作用单胺有关的慢性电功能障碍的有效主要参考点。此外,“束损伤理论”是用于理解慢性功能障碍的更准确的主要模型。 “束损伤理论”提倡在与慢性电功能障碍有关的状态下,突触单胺水平正常但不足,因此需要增加该水平以补偿由于现有损伤引起的慢性突触后电功能障碍。单胺假说无法准确地解释内源性状态下慢性神经元电流功能障碍的病因,因此仅停留在历史脚注上。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号